Drug Master Files for: metolazone
✉ Email this page to a colleague
metolazone Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
11958 | A | II | 5/2/1996 | AMRI RENSSELAER INC | METOLAZONE, USP |
16001 | I | II | 6/10/2002 | XIAN LIBANG PHARMACEUTICAL CO LTD | METOLAZONE USP |
30310 | A | II | 3/21/2016 | CENTAUR PHARMACEUTICALS PRIVATE LTD | METOLAZONE USP |
32868 | A | II | 6/28/2018 | BIOPHORE INDIA PHARMACEUTICALS PVT LTD | METOLAZONE USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information